
Cover image

Volume 11, Issue 3, March 2024
Review Articles
Confronting the Disruption of the Infectious Diseases Workforce by Artificial Intelligence: What This Means for Us and What We Can Do About It
With the rapid advancement of artificial intelligence, the field of infectious diseases faces both innovation and disruption. We provide considerations for infectious diseases specialists to leverage this growing technology while mitigating its risks.
A Baker's Dozen of Top Antimicrobial Stewardship Intervention Publications in 2022
The top 13 publications of 2022 describing an actionable antimicrobial stewardship intervention were selected by a modified Delphi technique. This summary will serve as a resource for readers seeking to stay up to date on successful antimicrobial stewardship strategies.
Clinical Characteristics and Outcomes of Endemic Mycoses After Solid Organ Transplantation: A Comprehensive Review
Endemic mycoses may cause severe disease among SOT recipients, especially those with epidemiologic risk. Fever, disseminated disease, and cytopenia are common. Heightened suspicion for these mycoses is needed to facilitate early recognition and reduce morbidity and mortality rates in SOT recipients.
Modeling Invasive Aspergillosis Risk for the Application of Prophylaxis Strategies
The Sankey approach provides a dynamic visual model to understand the changing risk of invasive aspergillosis from diagnosis of an underlying condition throughout the treatment journey. Future upgrades could include actionable links to references or bundles of pharmacologic or non-pharmacologic interventions.
Assessing the Appropriateness of Antimicrobial Prescribing in the Community Setting: A Scoping Review
Behavioral and Social Aspects of Infectious Diseases
Major Article
Patient Perspectives on Solid Organ Transplantation From Donors With Hepatitis C Viremia to Recipients Without Hepatitis C Viremia
Kidney, liver, heart, and lung transplant recipients who acquired hepatitis C from donor organs described positive experiences overall; however, some had concerns about hepatitis C transmission, treatment costs, and unexpected treatment delays, highlighting opportunities for improved education.
Clinical Trials and Therapeutics
Major Articles
Safety and Efficacy of 25 mg/kg and 35 mg/kg vs 10 mg/kg Rifampicin in Pulmonary TB: A Phase IIb Randomized Controlled Trial
Our randomized clinical trial compared safety and efficacy of high-dose rifampicin (R25/R35) against conventional dose (R10). We found that R35 was more toxic than R10. R25 was equally safe and more efficacious than R10; hence, it may be implemented for treatment shortening of drug-susceptible pulmonary tuberculosis.
Epidemiology and Risk Factors of Mycotic Aneurysm in Patients With Infective Endocarditis and the Impact of its Rupture in Outcomes. Analysis of a National Prospective Cohort
In this prospective multicenter cohort with 4,548 infective endocarditis cases, mycotic aneurysms (MA) developed in 2%, with half being intracranial. Rupture was common, correlating with poor prognosis. A notable portion of initially intact intracranial MA ruptured within the initial days.
Analysis of National Institutes of Health Funding for the COVID-19 Pandemic
The NIH disbursed more than $4 billion in funding to large consortiums and clinical trials to develop diagnostics, therapeutics, and vaccines. Approximately 8% of funding was used for R01 grants. Clinical trial sites were generally located in areas of high COVID-19 burden.
Early Versus Late Antipseudomonal β-Lactam Antibiotic Dose Adjustment in Critically Ill Sepsis Patients With Acute Kidney Injury: A Prospective Observational Cohort Study
This study investigated the timing of β-lactam antibiotic dose adjustment in sepsis patients with acute kidney injury. The findings indicated that delaying antipseudomonal β-lactam antibiotic dose adjustment was associated with reduced in-hospital mortality.
Safety and Immune Responses Following Anti-PD-1 Monoclonal Antibody Infusions in Healthy Persons With Human Immunodeficiency Virus on Antiretroviral Therapy
One of 4 participants administered anti-PD-1 antibody exhibited increased HIV-1–specific T-cell responses and transiently increased HIV-1 expression. Significant immune-related adverse events after a single, low dose of anti-PD-1 antibody may limit translating the benefits of anti-PD-1 therapies from cancer to HIV.
Incidence and Predictors of Tuberculosis-associated IRIS in People With HIV Treated for Tuberculosis: Findings From Reflate TB2 Randomized Trial
Integrase strand transfer inhibitor–based antiretroviral therapy (ART) did not increase the risk of tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) in the Reflate TB2 randomized controlled trial. Low CD4 counts and high HIV-RNA at ART initiation and extrapulmonary/disseminated TB were risk factors for TB-IRIS.
Effects of Neonatal BCG-Japan Versus BCG-Russia Vaccination on Overall Mortality and Morbidity: Randomized Controlled Trial From Guinea-Bissau (BCGSTRAIN II)
In a randomized controlled trial from Guinea-Bissau contrasting BCG-Japan and BCG-Russia, BCG strain was not associated with differences in all-cause morbidity and mortality by 6 weeks or 6 months of age. BCG-Japan produced more and larger BCG skin reactions.
Brief Report
Dalba Got Back? Use of Dalbavancin for the Treatment of Vertebral Osteomyelitis
Diagnostic Methods and Tools
Major Articles
MSG-15: Super-Bioavailability Itraconazole Versus Conventional Itraconazole in the Treatment of Endemic Mycoses—A Multicenter, Open-Label, Randomized Comparative Trial
Itraconazole is the mainstay therapy for endemic mycoses. Unfavorable pharmacokinetics lead to subtherapeutic levels and adverse effects. Super-bioavailability itraconazole is bioequivalent to conventional itraconazole, with similar clinical outcomes, but has fewer adverse events, possibly owing to lower drug-level variability.
Diagnosis and Treatment of Pneumonia in Urgent Care Clinics: Opportunities for Improving Care
We describe a novel population of urgent care clinic patients diagnosed and treated for community-acquired pneumonia. Variability in the use of chest imaging among patients diagnosed with pneumonia reveals opportunities for improving clinical decision-making support and antibiotic stewardship. Existing tools for predicting pneumonia severity which are based on ED and inpatient data overestimated the need for hospital admission.
Diagnostic Accuracy of Point-of-Care Gram Stains in Obstructive Pyelonephritis due to Ureteral Stones
Evaluation of Three Cytomegalovirus IgG Lateral Flow Assays for Rapid Determination of CMV Serostatus
Brief Report
Comparing Polymerase Chain Reaction Testing of Nasopharyngeal Swab and Lower Respiratory Tract Specimens for the Diagnosis of Pneumocystis jirovecii Pneumonia
Education and Training in Infectious Diseases
Brief Report
Which Topics Drive Dissemination? Alternative Bibliometrics Analysis of the Highest-Ranking Articles in 3 Infectious Diseases Journals Before COVID-19
Epidemiology and Disease Surveillance
Major Articles
Septic Arthritis of the Spinal Facet Joint: Review of 117 Cases
Septic arthritis of the facet joint is a distinct clinical syndrome typically involving the lumbar spine, and frequently associated with bacteremia, posterior epidural abscesses, and paraspinal pyomyositis. Neurologic outcomes are usually good with medical management alone.
Implementation of a Prospective Index-Cluster Sampling Strategy for the Detection of Presymptomatic Viral Respiratory Infection in Undergraduate Students
In a college population, an index-cluster sampling strategy in which clusters were established based on geographic proximity alone did not enrich for cases of respiratory viral transmission.
Do Infectious Diseases After Kidney Retransplantation Differ From Those After First Kidney Transplantation?
Personalized Infant Risk Prediction for Severe Respiratory Syncytial Virus Lower Respiratory Tract Infection Requiring Intensive Care Unit Admission
Timely identification of infants at highest risk of respiratory syncytial virus–related morbidity is key to prevention. We developed a personalized risk prediction tool using birth/postnatal data that may have applications in promoting immunoprophylaxis to prevent the most severe infant respiratory syncytial virus infections.
Resurgence of Respiratory Syncytial Virus in the Summer of 2021 in Denmark—a Large out-of-season Epidemic Affecting Older Children
Overestimation of Severe Acute Respiratory Syndrome Coronavirus 2 Household Transmission in Settings of High Community Transmission: Insights From an Informal Settlement Community in Salvador, Brazil
We found a high level of transmissibility of the SARS-CoV-2 BA.1* Omicron variant both within the community and households. Phylogenetic analysis suggests a diverse set of viruses were transmitted within the community and households, consistent with multiple introductions and high rates of incidence.
Clinical Presentation, Risk Factors, and Comparison of Laboratory Diagnostics for Seasonal Influenza Virus Among Cambodians From 2007 to 2020
The Strain and the Clinical Outcome of Clostridioides difficile Infection: A Meta-analysis
A systematic review (93 studies) and meta-analysis were conducted to assess the association between bacterial strains and complications, recurrence, and mortality in Clostridioides difficile infection. NAP1/BI/R027 was associated with unfavorable outcomes. Data on other strains were insufficient for significant conclusions.
Brief Reports
Risk of Hepatitis B Reactivation in Patients Receiving Ibrutinib: The National Veterans Affairs Cohort
Esophageal Candidiasis–Associated Hospitalizations: Declining Rates and Changes in Underlying Conditions, United States, 2010–2020
Cholera Deaths During Outbreaks in Uvira, Eastern Democratic Republic of the Congo, 10–35 Months After Mass Vaccination
Global Health and Infectious Diseases
Major Articles
Identifying Individuals at High Risk for HIV and Sexually Transmitted Infections With an Artificial Intelligence–Based Risk Assessment Tool
Sex and HIV Differences in Preserved Ratio Impaired Spirometry (PRISm) Among Ugandans Postpneumonia
Hypertension Among Cohort of Persons With Human Immunodeficiency Virus Initiated on a Dolutegravir-Based Antiretroviral Regimen in Ghana
Over half of adults with HIV initiated on a dolutegravir-based regimen developed hypertension, with a quarter of them developing it 6 months post–dolutegravir initiation. Incidence was higher in treatment-naive persons. Obesity and low high-density lipoprotein were risk factors for developing hypertension.
Genetic Susceptibility to Astrovirus Diarrhea in Bangladeshi Infants
We identified 2 genetic polymorphisms associated with greatly increased risk of astrovirus diarrheal infections in the first year of life, the A allele of rs75437404 (odds ratio, 2.71) and the C allele of rs75935441 (odds ratio, 4.17).
A Pilot Investigation of the Association Between Vpr Amino Acid Substitutions and Peripheral Immune Marker Levels in People With Human Immunodeficiency Virus: Implications for Neurocognitive Impairment
In South African people with HIV, the presence of Vpr amino acid G41 showed significant associations with higher levels of soluble urokinase plasminogen activator receptor compared to other amino acids at these positions.
Final 192-Week Efficacy and Safety Results of the ADVANCE Trial, Comparing 3 First-line Antiretroviral Regimens
Dolutegravir combined with tenofovir alafenamide or tenofovir disoproxil fumarate had high potency and safety, with no resistance to dolutegravir after 192 weeks, but it sustained weight gain, especially among women, those with low initiation CD4 counts, and those taking tenofovir alafenamide.
ID Public Health and Health Policy
Major Articles
Addressing Unmet PrEP Needs in Women: Impact of a Laboratory-Driven Protocol at an Urban, Essential Hospital
Attributable Cost of Adult Respiratory Syncytial Virus Illness Beyond the Acute Phase
Study findings indicate that acute-care costs for lower respiratory tract illness due to respiratory syncytial virus (RSV-LRTI) are high among US adults, and that attributable costs for RSV-LRTI remain high throughout the 1-year period following the acute phase of illness.
Infectious Diseases in Special Populations
Major Articles
The Burden and Impact of Early Post-transplant Multidrug-Resistant Organism Detection Among Renal Transplant Recipients, 2005–2021
In a retrospective study of 3,507 renal transplant recipients (RTRs) the detection of an MDRO during the early post-transplant (EPT) period was associated with death-censored allograft loss. This suggests the need for increased strategies to optimize prevention of MDROs colonization and infection.
GRAND PLAN: Safety and Efficacy of Glecaprevir/Pibrentasvir for the Treatment of Hepatitis C Virus Infection Among People Initially Disengaged From Health Care Who Use Drugs—A Systematic Multidisciplinary Approach
An Emergent Change in Epidemiologic and Microbiological Characteristics of Bloodstream Infections in Adults With Febrile Neutropenia Resulting From Chemotherapy for Acute Leukemia and Lymphoma at Reference Centers in Chile, Ecuador, and Peru
There are scarce epidemiologic data on febrile neutropenia infections in people with hematologic malignancies in Latin America. This retrospective and multicenter study offers updated knowledge regarding bloodstream infections, predominantly consisting of gram-negative rods with high rates of antibiotic resistance.
A Multicenter Assessment of the Outcomes and Toxicities of Foscarnet for Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex in Immunocompromised Patients
Acyclovir-resistant mucocutaneous herpes simplex virus (HSV) infection is a rare morbid illness typically treated with foscarnet. In this multicenter retrospective study of foscarnet therapy, half of 31 HSV episodes resolved during or after therapy; renal and electrolyte-related adverse events were common.
Association of Tecovirimat Therapy With Mpox Symptom Improvement: A Cross-sectional Study—King County, Washington, May–October 2022
We interviewed 115 persons with mpox who did and did not receive tecovirimat, and performed a multivariable regression analysis. Initiating tecovirimat within 5 days of symptom onset appeared to be associated with faster improvement of symptoms in patients with severe mpox.
Barriers to Hepatitis C Treatment and Interest in Telemedicine-Based Care Among Clients of a Syringe Access Program
Syringe access program (SAP) clients report high rates of hepatitis C virus (HCV) infection but limited access to treatment. They reported being more likely to get treated for HCV at the SAP and are comfortable with telemedicine-based appointments.
GeneXpert MTB/RIF Ultra vs Unstimulated Interferon γ (IRISA-TB) for the Diagnosis of Tuberculous Pericarditis in a Tuberculosis-Endemic Setting
Characteristics of Coronavirus Disease in Allogeneic Hematopoietic Stem Cell Transplantation During the Omicron Wave: A Single-Center Study
We present the clinical characteristics, outcomes, and risk factors for coronavirus disease 2019 (COVID-19) in allogeneic hematopoietic stem cell transplantation recipients during the Omicron wave. The recipients exhibited a low COVID-19–related mortality rate and high moderate-to-severe and prolonged disease incidence.
Cardiometabolic Health in Pregnancy and Postpartum: Findings From a Prospective Cohort Study in South Africa
A Prolonged Outbreak of Enteric Fever Associated With Illegal Miners in the City of Matlosana, South Africa, November 2020–September 2022
An increase in the number of enteric fever cases was observed in South Africa between 2020 and 2022. The outbreak predominantly affected illegal gold miners, likely due to the consumption of contaminated water while underground.
Characteristics and Outcomes of Pregnant Women Hospitalized With Laboratory-Confirmed Respiratory Syncytial Virus Before and During the COVID-19 Pandemic
Severe outcomes among pregnant women hospitalized with RSV infection were rare, and mild/asymptomatic infection was more frequently identified in pregnant women. In addition, more pregnant women delivered during their RSV-associated hospitalization during the COVID-19 pandemic vs before the pandemic.
Evaluating Clinical Sequelae of the Carbapenem-Valproate Interaction: A Retrospective Analysis
In this retrospective analysis, seizures and behavioral disturbances occurred following carbapenem administration in 46.3% and 50.8% of encounters, respectively, in patients with valproate exposure. Clinicians should be aware of this drug interaction and consider alternative antimicrobials when clinically appropriate.
Campylobacter Infections With and Without Bacteremia: A Comparative Retrospective Population-Based Study
Brief Reports
The Characteristics of Youth With Missed HIV Visits in Alabama
Risk of Infective Endocarditis in Streptococcus mitis Bloodstream Infections Among Patients with Neutropenia from Hematologic Malignancies
Pretreatment and Acquired Drug Resistance in Children With Human Immunodeficiency Virus Type 1 in Jos, Nigeria
“Electronic Phenotyping” Antimicrobials to Facilitate Outpatient Stewardship for Asymptomatic Bacteriuria and Urinary Tract Infection in Renal Transplant
Infection Prevention and Control
Major Articles
Neuroinvasive Bacillus cereus Infection in Immunocompromised Hosts: Epidemiologic Investigation of 5 Patients With Acute Myeloid Leukemia
We describe 5 health care–associated neuroinvasive Bacillus cereus infections. No point source was identified, and isolates were unrelated. Enhancing environmental cleaning, laundry management, and the neutropenic diet, as well as modifying empiric treatment protocols for febrile neutropenia, aborted the cluster.
Healthcare Provider N95 Respirator Contamination Worn Behind Face Shields With SARS-CoV-2 During Routine Clinical Care of Patients With COVID-19
We performed a prospective observational study to evaluate contamination of N95 respirators and face shields with SARS-CoV-2 when worn by healthcare providers giving care for SARS-CoV-2–positive patients housed in a COVID-19 unit. SARS-CoV-2 contamination was minimal.
Microbiology and Pathogenesis
Major Article
Two-Year Longitudinal Study Reveals That Long COVID Symptoms Peak and Quality of Life Nadirs at 6–12 Months Postinfection
Thirty-three percent of unvaccinated adults with mild-to-moderate acute COVID-19 experienced long COVID symptoms; 8% still had not returned to their pre-COVID-19 health status 24 months postinfection. Long COVID symptoms peaked and quality of life nadired at 6–12 months postinfection.
Outbreak Investigations
Major Article
Risk Factors of Developing Postinfectious Irritable Bowel Syndrome in Shigellosis Patients, 5 Years After Hospitalization During the Outbreak
Hospitalization due to Shigella gastroenteritis can strikingly increase the 5-year risk of developing irritable bowel syndrome. Clinical and background factors, such as education level, abdominal cramps, and prolonged diarrhea during hospitalization, can affect this risk.
Tropical and Emerging Infectious Diseases
Major Article
Clinical and Epidemiological Characteristics of the 2022 Mpox Outbreak in Spain (CEME-22 Study)
The SEIMC-CEME-22 study in Spain investigated the mpox outbreak. Predominantly middle-aged, cisgender men with a high HIV prevalence were affected, primarily through sexual transmission. Prominent symptoms included rash (95.7%) and fever (48.2%). STI were concurrently diagnosed. Diverse treatments were administered.
Brief Report
Eosinophilic Liver Abscess: A Case of Locally Acquired Fasciola hepatica in Alberta, Canada
Vaccines and Immunization
Major Articles
Global Safety Assessment of Adverse Events of Special Interest Following 2 Years of Use and 772 Million Administered Doses of mRNA-1273
This analysis evaluated observed-to-expected ratios for adverse events of special interest that were proposed in advance of COVID-19 vaccine use. Following administration of an estimated 772 908 958 doses of mRNA-1273, meaningful associations were found only for anaphylaxis, myocarditis, and pericarditis.
Real-world Effectiveness of mRNA COVID-19 Vaccines Among US Nursing Home Residents Aged ≥65 Years in the Pre-Delta and High Delta Periods
In a nationwide real-world study among nursing home residents, mRNA COVID-19 vaccines provided substantial protection against COVID-19–related death, even among prior COVID-19 survivors. Two-dose protection waned after 6 months. A third dose significantly boosted protection.
Novel ID Cases
Combination of Extended Antivirals With Antiretrovirals for Severe Mpox in Advanced Human Immunodeficiency Virus Infection: Case Series of 4 Patients
Perspectives
High-Volume, High-Acuity, and High-Impact Learning: Tips and Tricks for Infectious Diseases Training Programs
Infectious Diseases (ID) Training Program Directors have observed an increase in clinical volume and acuity. Specific goals and strategies to manage the volume and acuity while preserving quality education in both the inpatient and ambulatory settings are described
Ending Race-Conscious College Admissions and Its Potential Impact on the Infectious Disease Workforce
In this viewpoint, we discuss the consequences of the SCOTUS ruling ending race-conscious consideration for college admission, on diversifying the infectious disease workforce and combatting current and future pandemics. We provide strategies to mitigate this potential negative impact.